Exor becomes a long-term investor in Philips supporting the company’s strategy | EXOR
Summary
Our discussions have confirmed the strong and positive alignment between our long-term, supportive approach to our companies and Philips ambitious plans under the chairmanship of Feike Sijbesma and the executive team led by Roy Jakobs.For further information, please contact:Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving peoples health and well-being through meaningful innovation. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. For over a century, Exor has built great companies and made successful investments worldwide with a culture that combines entrepreneurial spirit and financial discipline. With a Net Asset Value of around EUR 33 billion, its portfolio is principally made up of companies in which Exor is the largest shareholder including Ferrari, Stellantis and CNH Industrial. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
